Open-Label Pilot Study of Lisdexamfetamine for Cocaine Dependence
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The proposed protocol is an open-label pilot study of the treatment of cocaine dependence
using lisdexamfetamine (LDX), a prodrug of d-amphetamine. The investigators plan to enroll 12
patients in an eight-week open-label trial to obtain preliminary data regarding the safety,
tolerability, and potential utility of lisdexamfetamine for treatment of cocaine dependence
and to determine an effective dosage range.